VEGFA and Ascites: In fact, there is evidence that inhibition of VPF/VEGF can lead to decreased formation of pleural effusions [3,8] and that antibodies directed against VPF/VEGF or VEGFR-2 can lead to a decrease in tumor vessel permeability and ascites formation [1,3,8-10].